Category:
API Equipment
Standard:
N;
China GMP
Form: capsule
Strength: 100mg
Indication: Chronic myeloid leukaemia (CML); Philadelphia chromosome positive acute lymphoblastic leukaemia (Ph-positive ALL)
This product category refers to **oral pharmaceutical capsules** formulated as **imatinib mesylate**, a tyrosine kinase inhibitor. Manufactured under strict **GMP standards**, these dosage units utilize **pharmaceutical-grade polymers** and **excipients** to ensure stability and bioavailability for systemic delivery.